Septal reduction therapies in hypertrophic cardiomyopathy: Comparison of surgical septal myectomy and alcohol septal ablation

Jeffrey B. Geske, Kyle W. Klarich, Steve R. Ommen, Hartzell V Schaff, Rick A. Nishimura

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Left ventricular outflow tract obstruction, either resting or labile, occurs in approximately 70% of patients with hypertrophic cardiomyopathy and is a major cause of symptoms. In patients with obstructive physiology and medically refractory symptoms, septal myectomy and alcohol septal ablation reduce the left ventricular outflow tract gradient and improve symptoms. Myectomy is more effective at gradient reduction compared with ablation, with lower need for subsequent pacemaker implantation. However, cohort studies and meta-analyses have shown short-term mortality and post-procedural functional classes are similar between procedures. In many centers alcohol septal ablation case volumes have surpassed myectomy. There remains significant controversy regarding choice of myectomy or ablation. This review describes the two septal reduction procedures, examines the available comparative data for clinical outcomes and discusses clinical considerations when selecting myectomy or ablation.

Original languageEnglish (US)
Pages (from-to)199-215
Number of pages17
JournalInterventional Cardiology (London)
Volume6
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Hypertrophic Cardiomyopathy
Alcohols
Ventricular Outflow Obstruction
Meta-Analysis
Cohort Studies
Mortality
Therapeutics

Keywords

  • alcohol septal ablation
  • hypertrophic cardiomyopathy
  • septal myectomy
  • septal reduction therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Septal reduction therapies in hypertrophic cardiomyopathy : Comparison of surgical septal myectomy and alcohol septal ablation. / Geske, Jeffrey B.; Klarich, Kyle W.; Ommen, Steve R.; Schaff, Hartzell V; Nishimura, Rick A.

In: Interventional Cardiology (London), Vol. 6, No. 2, 2014, p. 199-215.

Research output: Contribution to journalArticle

@article{fdb861247d2a46f4b3c9ce6b6fc1508a,
title = "Septal reduction therapies in hypertrophic cardiomyopathy: Comparison of surgical septal myectomy and alcohol septal ablation",
abstract = "Left ventricular outflow tract obstruction, either resting or labile, occurs in approximately 70{\%} of patients with hypertrophic cardiomyopathy and is a major cause of symptoms. In patients with obstructive physiology and medically refractory symptoms, septal myectomy and alcohol septal ablation reduce the left ventricular outflow tract gradient and improve symptoms. Myectomy is more effective at gradient reduction compared with ablation, with lower need for subsequent pacemaker implantation. However, cohort studies and meta-analyses have shown short-term mortality and post-procedural functional classes are similar between procedures. In many centers alcohol septal ablation case volumes have surpassed myectomy. There remains significant controversy regarding choice of myectomy or ablation. This review describes the two septal reduction procedures, examines the available comparative data for clinical outcomes and discusses clinical considerations when selecting myectomy or ablation.",
keywords = "alcohol septal ablation, hypertrophic cardiomyopathy, septal myectomy, septal reduction therapy",
author = "Geske, {Jeffrey B.} and Klarich, {Kyle W.} and Ommen, {Steve R.} and Schaff, {Hartzell V} and Nishimura, {Rick A.}",
year = "2014",
doi = "10.2217/ica.14.8",
language = "English (US)",
volume = "6",
pages = "199--215",
journal = "Interventional Cardiology (London)",
issn = "1755-5302",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Septal reduction therapies in hypertrophic cardiomyopathy

T2 - Comparison of surgical septal myectomy and alcohol septal ablation

AU - Geske, Jeffrey B.

AU - Klarich, Kyle W.

AU - Ommen, Steve R.

AU - Schaff, Hartzell V

AU - Nishimura, Rick A.

PY - 2014

Y1 - 2014

N2 - Left ventricular outflow tract obstruction, either resting or labile, occurs in approximately 70% of patients with hypertrophic cardiomyopathy and is a major cause of symptoms. In patients with obstructive physiology and medically refractory symptoms, septal myectomy and alcohol septal ablation reduce the left ventricular outflow tract gradient and improve symptoms. Myectomy is more effective at gradient reduction compared with ablation, with lower need for subsequent pacemaker implantation. However, cohort studies and meta-analyses have shown short-term mortality and post-procedural functional classes are similar between procedures. In many centers alcohol septal ablation case volumes have surpassed myectomy. There remains significant controversy regarding choice of myectomy or ablation. This review describes the two septal reduction procedures, examines the available comparative data for clinical outcomes and discusses clinical considerations when selecting myectomy or ablation.

AB - Left ventricular outflow tract obstruction, either resting or labile, occurs in approximately 70% of patients with hypertrophic cardiomyopathy and is a major cause of symptoms. In patients with obstructive physiology and medically refractory symptoms, septal myectomy and alcohol septal ablation reduce the left ventricular outflow tract gradient and improve symptoms. Myectomy is more effective at gradient reduction compared with ablation, with lower need for subsequent pacemaker implantation. However, cohort studies and meta-analyses have shown short-term mortality and post-procedural functional classes are similar between procedures. In many centers alcohol septal ablation case volumes have surpassed myectomy. There remains significant controversy regarding choice of myectomy or ablation. This review describes the two septal reduction procedures, examines the available comparative data for clinical outcomes and discusses clinical considerations when selecting myectomy or ablation.

KW - alcohol septal ablation

KW - hypertrophic cardiomyopathy

KW - septal myectomy

KW - septal reduction therapy

UR - http://www.scopus.com/inward/record.url?scp=84900447371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900447371&partnerID=8YFLogxK

U2 - 10.2217/ica.14.8

DO - 10.2217/ica.14.8

M3 - Article

AN - SCOPUS:84900447371

VL - 6

SP - 199

EP - 215

JO - Interventional Cardiology (London)

JF - Interventional Cardiology (London)

SN - 1755-5302

IS - 2

ER -